| |
| |
|
| Insider
Information: |
Ellin Robert S |
| Relationship: |
Officer, Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
26,081,667 |
|
|
Indirect Shares
|
486,187,368 |
|
|
| Direct
Value |
$15,283,880 |
|
|
|
Indirect Value
|
$67,911,072 |
|
|
| Total
Shares |
512,269,035 |
|
|
| Total
Value |
$83,194,952 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
61
|
2
|
|
Stock
price went up :
|
47
|
2
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.4
|
2.0
|
| Percentage
Gain/Loss : |
 28.2%
|
171.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PolarityTE, Inc |
PTE |
10% Owner |
2009-12-23 |
2,433,650 |
2006-12-15 |
3,095,486 |
Premium* |
|
|
Command Security Corp |
MOC |
10% Owner |
2012-02-21 |
679,914 |
2010-12-28 |
568,924 |
Premium* |
|
|
Shells Seafood Restaurants Inc |
SHLLQ |
Director, 10% Owner |
2004-11-12 |
0 |
2005-03-09 |
600,000 |
Premium* |
|
|
ProLink Holdings Corp |
PLKH |
SEE REMARKS, Director,... |
2005-12-23 |
4,888,249 |
2005-12-23 |
6,314,927 |
Premium* |
|
|
Radiologix Inc |
RGX |
10% Owner |
2006-06-30 |
2,220,358 |
2006-04-20 |
0 |
Premium* |
|
|
Protagenic Therapeutics Ord Shs |
PTIX |
Director, 10% Owner |
2010-01-06 |
1,792,695 |
2007-02-12 |
429,750,000 |
Premium* |
|
|
Indiepub Entertainment Inc |
IPUB |
10% Owner |
2010-01-08 |
4,102,553 |
2008-10-30 |
9,551,908 |
Premium* |
|
|
Mandalay Digital Group Inc |
MNDL |
10% Owner |
2014-04-25 |
3,668,275 |
2014-04-25 |
3,132,786 |
Premium* |
|
|
Lateral Media Inc |
LTLM |
Director, 10% Owner |
2010-01-08 |
4,106,378 |
2008-12-18 |
8,659,036 |
Premium* |
|
|
Eterna Therapeutics Inc |
ERNA |
10% Owner |
2020-08-13 |
421 |
2020-08-13 |
16,194 |
Premium* |
|
|
Noble Medical Technologies Inc |
NBLM |
Officer, Director |
|
0 |
2011-07-01 |
3,978,600 |
Premium* |
|
|
Liveone Ord Shs |
LVO |
CEO & Chairman, Direct... |
2024-04-01 |
2,089,666 |
2024-04-01 |
19,654,656 |
Premium* |
|
|
Podcastone Ord Shs |
PODC |
Officer, Director |
2023-09-07 |
99,508 |
2023-09-07 |
864,851 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
448 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 18
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-06 |
4 |
B |
$2.09 |
$5,847 |
I/I |
2,800 |
17,217,041 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-09 |
4 |
B |
$1.93 |
$12,711 |
I/I |
6,600 |
17,223,641 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-10 |
4 |
B |
$2.09 |
$5,842 |
I/I |
2,796 |
17,226,437 |
2.56 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-10 |
4 |
B |
$2.56 |
$9,463 |
I/I |
3,700 |
151,644 |
1.5 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-11 |
4 |
B |
$2.31 |
$5,092 |
I/I |
2,200 |
153,844 |
1.5 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-11 |
4 |
B |
$2.28 |
$2,056 |
D/D |
900 |
152,412 |
2.37 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-11 |
4 |
B |
$2.48 |
$6,698 |
I/I |
2,700 |
17,229,137 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-11 |
4 |
B |
$2.48 |
$899 |
D/D |
362 |
159,104 |
3.15 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-12 |
4 |
B |
$2.26 |
$16,852 |
I/I |
7,451 |
161,295 |
1.5 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-12 |
4 |
B |
$2.64 |
$6,929 |
I/I |
2,621 |
17,231,758 |
2.56 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-13 |
4 |
B |
$2.27 |
$3,516 |
D/D |
1,551 |
153,963 |
2.37 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-13 |
4 |
B |
$2.64 |
$5,283 |
I/I |
2,000 |
17,233,758 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-13 |
4 |
B |
$2.77 |
$1,387 |
D/D |
500 |
159,604 |
3.15 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-16 |
4 |
B |
$2.25 |
$4,277 |
I/I |
1,900 |
17,200,787 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-17 |
4 |
B |
$2.18 |
$2,615 |
I/I |
1,200 |
17,201,987 |
2.56 |
- |
|
| LVO |
Liveone Ord Shs |
CEO & Chairman |
• • • |
2019-09-18 |
4 |
B |
$2.16 |
$865 |
I/I |
400 |
17,202,387 |
2.56 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-24 |
4 |
B |
$2.44 |
$57,474 |
I/I |
23,550 |
184,845 |
1.5 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-25 |
4 |
B |
$2.81 |
$14,475 |
I/I |
5,150 |
189,995 |
1.5 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-26 |
4 |
B |
$2.95 |
$14,245 |
I/I |
4,831 |
194,826 |
1.5 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-09-30 |
4 |
B |
$3.33 |
$333 |
I/I |
100 |
194,926 |
1.42 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-10-01 |
4 |
B |
$3.43 |
$718 |
I/I |
200 |
195,126 |
1.42 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-10-03 |
4 |
B |
$3.12 |
$827 |
I/I |
265 |
195,391 |
1.42 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-10-04 |
4 |
B |
$2.90 |
$372 |
I/I |
128 |
195,519 |
1.42 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-10-08 |
4 |
B |
$3.67 |
$367 |
I/I |
100 |
195,619 |
1.42 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-10-14 |
4 |
B |
$3.66 |
$1,097 |
D/D |
300 |
154,263 |
2.37 |
- |
|
448 Records found
|
|
Page 13 of 18 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
